Loading markets…

Cogent Biosciences, Inc. (COGT) forecast

Cogent Biosciences, Inc. (COGT) forecast: price $31.08, trailing P/E -13.52, forward P/E 35.97. How to read the street's path.

$31.08Price
$5.39BMarket cap
-13.52P/E ?
35.97Forward P/E ?
0.00%Dividend yield ?

The live COGT price is $31.08. Trailing P/E is -13.52 and forward P/E is 35.97. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the COGT forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full COGT quote · Dividends · Price prediction · Academy

Questions

What is COGT's forward P/E?

The latest forward P/E on Stocklytics is 35.97, against a trailing P/E of -13.52 and a price of $31.08.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.